February 13, 2020
San Diego Marriott La Jolla, San Diego, CA, USA
9:00 AM–3:30 PM
Join us at the San Diego Marriott La Jolla to hear how ACD/Labs' software is being used in R&D labs like yours to digitize and effectively manage analytical data, and increase efficiency. Learn about solutions that are providing real benefits for scientists involved in metabolite identification, NMR spectroscopy, product development, and CMC. Also, we are proud to introduce ground-breaking, web-based software in support of high throughput experimentation; be among the first to see the software in action.
Network with colleagues and peers, and use this opportunity to provide feedback about how ACD/Labs can help address your most complex challenges through future developments.
9:00–10:00 | Registration and Coffee |
10:00–10:15 | Welcome ACD/Labs |
10:15–10:50 | Data Utilization and the Future of Industrial Informatics: Practical Considerations to Maximize Value Andrew Anderson, Vice President, Innovation and Informatics Strategy, ACD/Labs |
10:50–11:30 | Chiral Separations Workflow Automation, a Chiral Methods Database and a Unified Database for Analytical Knowledge Management Larry Miller, Senior Principal Scientist, Discovery Attribute Sciences, Amgen |
11:30–12:00 | Accelerated and Comprehensive Metabolite Identification Carol Preisig, Ph.D., MBA, Regional Account Manager, United States, West Region, ACD/Labs |
12:00–1:00 | Lunch |
1:00–1:30 | NMR Characterization, Impurity Profiling and Registration Workflow Tsang-Lin Hwang, Ph.D., Principal Scientist, Process Development, Amgen |
1:30–2:30 | Improving CMC Development Through Improved Decision-Support Capabilities Jordan Stobaugh, Ph.D., Principal Research Scientist, Analytical R&D, Data Strategy & Management, AbbVie |
2:30–3:00 | Web-based Software for the Automated Planning, Execution, and Analysis of High Throughput Experiments Carol Preisig, Ph.D., MBA, and Jessica Litman, Ph.D., ACD/Labs |
3:00–3:10 | Raffle and Door Prizes Bianca Lasalandra, Manager, Inside Sales |
3:10–3:20 | Closing Remarks ACD/Labs |